Healixia News - page 11

March 28, 2022

Call for an important projects of common European interest in the health sector

The FPS Economy published a call for interest from the Belgian federal and regional authorities for important projects of common European interest. The call is intended for economic operators who wish to take part in innovative projects at European level through various partnerships. The first documents should be sent by 30 March 2022 at the latest.

Source: FAMHP

March 22, 2022

Fight against antibiotic resistance: Amukin (amikacin) available again

Het FAGG doet inspanningen om essentiële antibiotica op de markt te houden of te brengen. Een positief resultaat daarvan is dat Amukin na drie jaar afwezigheid op de markt nu opnieuw beschikbaar is.

Bron: FAGG

L'AFMPS s'efforce de maintenir ou de mettre sur le marché des antibiotiques essentiels. Cet effort a notamment conduit à un résultat important : Amukin est à nouveau disponible après trois ans d'absence du marché.

Source: AFMPS

March 22, 2022

PRAC March 2022 – Update on COVID-19 vaccines and new safety information for dexmedetomidine

During its March 2022 meeting, the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency has recommended a change to the product information for the COVID-19 vaccines of Janssen and Moderna. The Committee also discussed a direct healthcare professional communication containing important safety information for dexmedetomidine.

Source: FAMHP

March 14, 2022

Message from the IFAPP President

An update on the collaboration between IFAPP and IFAPP Academy

March 14, 2022

IFAPP Today newsletter - March 2022

Source: IFAPP

Please find here the link to the IFAPP TODAY newsletter of March 2022.

February 28, 2022

The FAMHP encourages non-profit organisations and academia to apply for the pilot project for the repurposing of authorised medicines

The FAMHP takes part in the European pilot project for the repurposing of medicines to support non-profit organisations and academia. The project was launched by the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA).

Source: FAMHP

February 25, 2022

Healixia is looking for a Director

Two years after the start of Healixia, we are ready for the next step. We want to further establish our growth and are looking for a Director to help us do so. Are you interested or do you know someone who might be?

February 25, 2022

Coronavirus: monthly update of COVID-19 vaccines 24 February 2022

Coronavirus: maandelijks overzicht bijwerkingen COVID-19-vaccins van 24 februari 2022

Coronavirus : aperçu mensuel des effets indésirables des vaccins contre la COVID-19 du 24 février 2022

Source: FAMHP

February 24, 2022

The FAMHP publishes its 2020 annual report with testimonials about the first year of the pandemic

In addition to the usual facts and figures, the FAMHP's 2020 annual report includes testimonials from staff members who had to face difficult situations in the field. These stories show that there was tremendous stress and pressure, but also a lot of dedication and professionalism.

Source: FAMHP

February 21, 2022

PRAC February 2022

During its February 2022 meeting, the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency recommended suspending hydroxyethyl-starch solutions for infusion from the market. Furthermore, the PRAC starts a safety review of Janus kinase inhibitors for inflammatory disorders.

Source: FAMHP